Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
MRNA Insider Trading and Fund Holdings (Moderna, Inc.) · https://wallstpal.com/stock/mrna/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 1682852

Moderna, Inc. (MRNA): Insider Trades and Fund Holdings

In the past 12 months, Moderna, Inc. insiders reported no open-market purchases and 9 sales worth $68.9M; 9 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$68.9MSold by insiders, 12 months
1Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Oct 15, 2026Insider salePresident Stephen Hoge sold $8.6 million under a 10b5-1 plan
  2. Oct 15, 2026Planned saleHoge Stephen (officer) filed notice to sell about $8.6 million around Oct 15, 2026
  3. Oct 14, 2026Insider salePresident Stephen Hoge sold $8.4 million under a 10b5-1 plan
  4. Oct 14, 2026Planned saleHoge Stephen (officer) filed notice to sell about $8.4 million around Oct 14, 2026
  5. Sep 30, 2026NewsCompany reported: Executive or director change
  6. Sep 24, 2026CongressRep. Maria Elvira Salazar partial sell $1K–$15K
  7. Sep 15, 2026Insider salePresident Stephen Hoge sold $5.9 million under a 10b5-1 plan
  8. Sep 15, 2026Planned saleHoge Stephen (officer) filed notice to sell about $5.9 million around Sep 15, 2026
  9. Sep 14, 2026Insider salePresident Stephen Hoge sold $5.8 million under a 10b5-1 plan
  10. Sep 14, 2026Planned saleHoge Stephen (officer) filed notice to sell about $5.8 million around Sep 14, 2026
  11. Sep 10, 2026Insider saleCFO James M. Mock sold $4.7 million under a 10b5-1 plan (9 days after: signed a material agreement)
  12. Sep 10, 2026Planned saleMock James M (officer) filed notice to sell about $4.7 million around Sep 10, 2026
  13. Sep 1, 2026NewsCompany reported: Signed a material agreement
  14. Sep 1, 2026Insider saleGeneral Counsel Shannon Thyme Klinger sold $485,766 under a 10b5-1 plan (0 days after: signed a material agreement)
  15. Sep 1, 2026Planned saleKlinger Shannon Thyme (officer) filed notice to sell about $485,766 around Sep 1, 2026
  16. Aug 19, 2026CongressRep. Maria Elvira Salazar partial sell $1K–$15K
  17. Aug 19, 2026CongressRep. Maria Elvira Salazar buy $1K–$15K
  18. Aug 5, 2026Insider saleCEO Stephane Bancel sold $28.7 million under a 10b5-1 plan (5 days after: quarterly or annual results)
  19. Aug 5, 2026Planned saleBancel Stephane (officer, director) filed notice to sell about $29 million around Aug 5, 2026
  20. Jul 31, 2026NewsCompany reported: Quarterly or annual results
  21. Jul 15, 2026Insider salePresident Stephen Hoge sold $3.6 million under a 10b5-1 plan
  22. Jun 30, 2026FundBridgewater Associates cut 85% in Q2 2026 (13F filed Aug 14, 2026)
  23. Jun 30, 2026FundRenaissance Technologies sold out in Q2 2026 (13F filed Aug 13, 2026)
  24. Jun 15, 2026Insider salePresident Stephen Hoge sold $2.7 million under a 10b5-1 plan

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 16, 2026.

Recent MRNA insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 16Oct 15Stephen HogePresidentPresident▼ SELL10b5-139,145220.72$8.64M−2.3%Form 4 ↗
Oct 16Oct 14Stephen HogePresidentPresident▼ SELL10b5-139,224213.48$8.37M−2.4%Form 4 ↗
Sep 16Sep 15Stephen HogePresidentPresident▼ SELL10b5-140,281146.07$5.88M−2.5%Form 4 ↗
Sep 16Sep 14Stephen HogePresidentPresident▼ SELL10b5-140,294144.13$5.81M−2.6%Form 4 ↗
Sep 14Sep 10James M. MockCFOCFO▼ SELL10b5-134,836134.49$4.69M−37%Form 4 ↗
Sep 3Sep 1Shannon Thyme KlingerGeneral CounselGeneral Counsel▼ SELL10b5-13,471139.95$486K−4.5%Form 4 ↗
Aug 7Aug 5Stephane BancelCEOCEO▼ SELL10b5-1499,24657.52$28.7M−7.5%Form 4 ↗
Jul 16Jul 15Stephen HogePresidentPresident▼ SELL10b5-153,33667.60$3.61M−3.5%Form 4 ↗
Jun 17Jun 15Stephen HogePresidentPresident▼ SELL10b5-153,33651.37$2.74M−3.5%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Stephen HogePresident0$06$35.1MOct 16, 2026
James M. MockCFO0$01$4.69MSep 14, 2026
Shannon Thyme KlingerGeneral Counsel0$01$486KSep 3, 2026
Stephane BancelCEO0$01$28.7MAug 7, 2026

Trades by members of Congress

Reported under the STOCK Act. Amounts are ranges from the form. All Congress trades →

Congress trades in MRNA
FiledMemberTypeOwnerAmountTradedDays to reportReport
Oct 7▼ PARTIAL SELLMember$1K–$15KSep 2413PDF ↗
Sep 9▼ PARTIAL SELLMember$1K–$15KAug 1921PDF ↗
Sep 9▲ BUYMember$1K–$15KAug 1921PDF ↗

Buybacks and executive pay

Moderna, Inc. spent $2 million buying back its own shares in 2025.

From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.

Filing quality

A All 9 insider trades reported on time. How it is graded

Tracked funds that report MRNA

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Bridgewater AssociatesQ2 202611,527$807K0.00%▼ −84.6%
Renaissance TechnologiesQ2 20260$00.00%▼ Sold out
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →